Urinary hypoxanthine and xanthine levels in acute coronary syndromes

International Journal of Clinical and Laboratory Research

Volumn 29, Issue 4, 1999, Pages 162-165

  Turgan, N ^a   Boydak, B ^a   Habif, S ^a   Gulter C ^a   Senol B ^a   Mutaf, I ^a   Ozmen D ^a   Bayindir, O ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Acute coronary syndromes; Hypoxanthine; Purine degradation products; Xanthine

Indexed keywords

BIOLOGICAL MARKER; CREATINE; HYPOXANTHINE; PURINE DERIVATIVE; URIC ACID; XANTHINE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; METABOLISM; MIDDLE AGED; UNSTABLE ANGINA PECTORIS; UREA NITROGEN BLOOD LEVEL; URINE;

ACUTE DISEASE; ADULT; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CREATINE; FEMALE; HUMANS; HYPOXANTHINE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PURINES; URIC ACID; XANTHINE;

ANGINA;

EID: 0033511706     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005990050084     Document Type: Article

References (27)

1. Valik D, Jones JD. Hereditary disorders of purine metabolism: identification of their biochemical phenotypes in the clinical laboratory. Mayo Clin Proc 1997;72:719.
2. Curio R, Voit EO, Sorribas A, Cascante M. Validation and steady-state analysis of a power-law model of purine metabolism in man. Biochem J 1997;324:761.
3. Valtysson J, Persson L, Hillered L. Extracellular ischaemia markers in repeated global ischaemia and secondary hypoxaemia monitored by microdialysis in rat brain. Acta Neurochir (Wien) 1998;140:387.
4. Quinlan GJ, Lamb NJ, Tilley R, Evans TW, Gutteridge JM. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity and mortality. Am J Respir Crit Care Med 1997;155:479.
5. Fellman V, Raivio KO. Reperfusion injury as the mechanism of brain damage after perinatal asphyxia. Pediatr Res 1997;41: 599.
6. Marro PJ, Baumgart S. Delivoria-Papadopoutos M, Zirin S, Corcoran L, McGaurn SP. et al. Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation. Pediatr Res 1997;41:513.
7. Gattullo D, Pagliaro P, Losano G. Mechanisms of ischemic preconditioning:relation with ischemia-reperfusion injury. G Ital Cardiol 1997;27:288.
8. Many A, Hubel C, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia. revisited. Am J Obstet Gynecol 1996.174:288.
9. Zhang Z, Blake DR, Stevens CR, Kanzcler JM, Winyard PG, Symons PC, et al. Both xanthine dehydrogenase xanthine oxidase can oxidise NADH to generate reactive oxygen species. Free Radic Res 1998;28:151.
10. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease.Acta Paediatr 1996:85:1.
11. Busse M, Vaupel P. Accumulation of purine catabolites in solid tumors exposed to therapeutic hyperthermia. Experientia 1996;52:469.
12. Kunz TW, Kabra PM, Booth BE, Al-Bander HA, Portale AA. Serena BG, et al. Liquid-chromatographic measurements of inosine, hypoxanthine and xanthine in studies of fructose-induced degradation of adenine nucleotides in humans and rats. Clin Chem 1986;32:782.
13. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl Med 1985;312:159.
14. Dhalla NS, Golfman L, Takeda S, Takeda N, Nagano M. Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review. Can J Cardiol 1999;15:587.
15. Ferrari R, Agnoletti L, Comini L, Gaia G, Bachetti T. Cargnoni A, et al. Oxidative stress during myocardial ischemia and heart failure. Eur Heart J 1998;19 [Suppl B]:B2.
16. Hogg N. Free radicals in disease. Semin Reprod Endocrinol 1998;16:241.
17. Gimpel JA, Lahpor JR. Molen AJ van der, Domen J, Hitchcock JF. Reduction of reperfusion injury of human myocardium by allopurinol: a clinical study. Free Radic Biol Med 1995;19:251.
18. Castelli P, Condemi AM, Brambillasca C, Fundaro P, Botta M, Lemma M, et al. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery. J Cardiovasc Pharmacol 1995;25:119.
19. Shadid M, Van Bel F, Steendjik P, Dorrepaal CA, Moison R, Velde ET van der, Baan J. Pretreatment with allopurinol in cardiac hypoxic-ischemic reperfusion injury in newborn lambs exerts its beneficial effect through afterload reduction. Basic Res Cardiol 1999;94:23.
20. Koyama K, Kaya M, Ishigaki T, Tsujita J, Hori S, Seino T, Kasugai A. Role of xanthine oxidase in delayed lipid peroxidation in rat liver induced by acute exhausting exercise. Eur J Appl Physiol 1999;80:28.
21. Konaka A, Nishijama M, Tanaka A, Kunikata T, Kato S, Takeuchi K. Nitric oxide. Superoxide radicals and mast cells in the pathogenesis of indomethacin,induced small intestinal lesions in rats. J Physiol Pharmacol 1999;50:25.
22. Mishra OP, Delivoria-Papadopoulos M. Cellular mechanisms of hypoxic injury in the developing brain. Brain Res Bull 1999;48:233.
23. Harkness RA. Hypoxanthine, xanthine and uridine in body fluids,indicators of ATP depletion. J Chromatogr 1988;429:255.
24. Hartmann F, Kampmann M, Frey N, Müller-Bardorff M, Katus HA. Biochemical markers in the diagnosis of coronary artery disease. Eur Heart J 1998;19 [Suppl N]:N2.
25. Ueda S, Ikeda U, Yamamoto K, Takahashi M, Nishinasa M, Nago N, Shimada K. C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction. Am Heart J 1996;131:857.
26. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462.
27. Ridker PM, Cushman M, Stampher MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973.